Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography(OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution, in real time, to depths of 1 mm or more.
Our breakthrough technology enables in-vivo capture, visualization and measurement of biological details that are too small to be seen with ultrasound, and too deep for conventional microscopy.
Type | Private | |
Founded | 2006 | |
HQ | Maidstone, GB | Map |
Website | vivosight.com |
Founding Date | 2006 |
Michelson Diagnostics total Funding | $10.8 m |
Michelson Diagnostics latest funding size | $2.85 m |
Time since last funding | 7 years ago |
Michelson Diagnostics investors | Octopus Investments, London Business Angels, Octopus Ventures, Smith & Nephew, Catapult Ventures |
GBP | |
---|---|
Revenue (FY, 2015) | 630.2k |
Revenue growth (FY, 2014 - FY, 2015), % | (49.6%) |
Gross profit (FY, 2015) | 282.7k |
Gross profit margin (FY, 2015), % | 44.9% |
Net income (FY, 2015) | (2.5m) |
EBITDA (FY, 2015) | (2.5m) |
EBIT (FY, 2015) | (2.7m) |
Cash (30-Sept-2018) | 610.8k |
GBP | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 |
---|---|---|---|---|---|
Revenue | 250.8k | 401.0k | 662.9k | 1.3m | 630.2k |
Revenue growth, % | (50%) | ||||
Cost of goods sold | 133.9k | 125.3k | 128.6k | 212.9k | 347.6k |
Gross profit | 116.9k | 275.7k | 534.2k | 1.0m | 282.7k |
GBP | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 144.9k | 365.9k | 606.2k | 393.2k | 1.4m | 2.0m | 254.4k | 393.7k | 1.4m | 182.0k | 143.3k | 610.8k |
Accounts Receivable | 42.3k | 74.2k | 135.2k | 83.9k | 6.1k | 31.0k | 27.3k | 202.2k | 33.5k | 4.7k | 154.6k | 50.3k |
Inventories | 62.6k | 78.0k | 232.4k | 138.1k | 272.5k | 164.0k | 488.1k | 556.6k | 565.0k | 515.4k | 270.1k | |
Current Assets | 187.2k | 585.1k | 982.7k | 709.6k | 1.6m | 2.4m | 642.4k | 1.8m | 2.8m | 1.2m | 1.1m | 1.5m |
GBP | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 |
---|---|---|---|---|---|
Net Income | (745.3k) | (1.4m) | (2.1m) | (1.8m) | (2.5m) |
Cash From Operating Activities | (697.3k) | (1.6m) | (1.7m) | (1.9m) | (2.0m) |
Cash From Financing Activities | 1.9m | 2.4m | 2.2m | 3.6m | |
Net Change in Cash | 1.0m | 562.6k | (1.7m) | 139.3k | 998.8k |
GBP | FY, 2007 |
---|---|
Financial Leverage | 1.2 x |
When was Michelson Diagnostics founded?
Michelson Diagnostics was founded in 2006.
Who are Michelson Diagnostics key executives?
Michelson Diagnostics's key executives are Jon Holmes and Martin Johns.
How many employees does Michelson Diagnostics have?
Michelson Diagnostics has 10 employees.
What is Michelson Diagnostics revenue?
Latest Michelson Diagnostics annual revenue is £630.2 k.
What is Michelson Diagnostics revenue per employee?
Latest Michelson Diagnostics revenue per employee is £63 k.
Who are Michelson Diagnostics competitors?
Competitors of Michelson Diagnostics include LaVision BioTec, Trice Medical and Magnetic Insight.
Where is Michelson Diagnostics headquarters?
Michelson Diagnostics headquarters is located at Eclipse House Sittingbourne Rd, Maidstone.
Where are Michelson Diagnostics offices?
Michelson Diagnostics has offices in Maidstone and Atascadero.
How many offices does Michelson Diagnostics have?
Michelson Diagnostics has 2 offices.
Receive alerts for 300+ data fields across thousands of companies